Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy

Obstetrics and Gynecology

Volumn 122, Issue 4, 2013, Pages 745-751

  Skubisz, Monika M ^a,b,c   Horne, Andrew W ^a,b,c   Johns, Terrance G ^a,b,c   Nilsson, Ulrika W ^a,b,c   Duncan, W Colin ^a,b,c   Wallace, Euan M ^a,b,c   Critchley, Hilary O D ^a,b,c   Tong, Stephen ^a,b,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GEFITINIB; METHOTREXATE;

ACNE; ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECTOPIC PREGNANCY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIVER TOXICITY; LUNG TOXICITY; MONOTHERAPY; NEPHROTOXICITY; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; POLYPHARMACY; PRIORITY JOURNAL; SALPINGECTOMY; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; ANTINEOPLASTIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; QUINAZOLINES;

EID: 84887238944     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182a14cfb     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention (CDC). Ectopic pregnancy: United States, 1990-1992. MMWR Morb Mortal Wkly Rep 1995;44:46-8.
2. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mother's lives: reviewing maternal deaths to make motherhood safer 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London (United Kingdom): 2007:8.
3. Mol F, Mol BW, Ankum WM, van der Veen F, Hajenius PJ. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: A systematic review and meta-analysis. Hum Reprod Update 2008;14:309-19.
4. Jurkovic D, Wilkinson H. Diagnosis and management of ectopic pregnancy. BMJ 2011;342:d3397.
5. Herbst RS, Fukuoka M, Baselga J. Gefitinib- A novel targeted approach to treating cancer. Nat Rev Cancer 2004;4:956-65.
6. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002;99:4465-70.
7. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, et al. BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009;10:R130.
8. LaMarca HL, Dash PR, Vishnuthevan K, Harvey E, Sullivan DE, Morris CA, et al. Epidermal growth factorstimulated extravillous cytotrophoblast motility is mediated by the activation of PI3-K, Akt and both p38 and p42/44 mitogen- Activated protein kinases. Hum Reprod 2008;23:1733-41.
9. Johnstone ED, Mackova M, Das S, Payne SG, Lowen B, Sibley CP, et al. Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta 2005;26:548-55.
10. Wolff GS, Chiang PJ, Smith SM, Romero R, Armant DR. Epidermal growth factor-like growth factors prevent apoptosis of alcohol-exposed human placental cytotrophoblast cells. Biol Reprod 2007;77:53-60.
11. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995;269:234-8.
12. Cohen MH, Williams GA, Sridhara R, Chen G, McGuinn WD Jr, Morse D, et al. United States Food and Drug Administration Drug Approval summary: gefitinib (ZD1839; Iressa) tablets. Clin Cancer Res 2004;10:1212-8.
13. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358:1160-74.
14. Nilsson UW, Johns TG, Wilmann T, Kaitu'u-Lino T, Whitehead C, Dimitriadis E, et al. Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth. Obstet Gynecol 2013;122:737-44.
15. van Zandwijk N. Tolerability of gefitinib in patients receiving treatment in everyday clinical practice. Br J Cancer 2003;89 (suppl 2):9-14.
16. Cataldo VD, Gibbons DL, Perez-Soler R, Quintas-Cardama A. Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med 2011;364:947-55.
17. Hoag JB, Azizi A, Doherty TJ, Lu J, Willis RE, Lund ME. Association of cetuximab with adverse pulmonary events in cancer patients: A comprehensive review. J Exp Clin Cancer Res 2009;28:113.
18. Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010;376:717-29.
19. Chetty M, Elson J. Treating non-tubal ectopic pregnancy. Best Pract Res Clin Obstet Gynaecol 2009;23:529-38.